University of Leeds spin-out Tissue joined the Alternative Investment Market in June 2010 through the reverse takeover of listed Oxeco.
Tissue Regenix, a UK-listed healthcare company spun out of the University of Leeds, is trying to raise £25m ($35m) through a share placing.
The university retains 5.2% of Tissue ahead of the placing after the company was incorporated in May 2006 to commercialise the academic research of its professors, Eileen Ingham and John Fisher.
Tissue joined the Alternative Investment Market in June 2010 through the reverse takeover of listed Oxeco.
